CYP19A1 and breast cancer: More interestingly, resveratrol is able to synergistically enhance the effect of aromatase inhibitors on hormone-sensitive BC cells by modulating aromatase activity at the epigenetic level, sustaining the hypothesis of its co-therapeutic benefits [177].